Alzheimer Check-up

Cognitive decline associated with Alzheimer's disease and related conditions often begins years before noticeable symptoms affect daily life. This programme is structured to detect early changes through complementary neurological, neuropsychological, and imaging investigations.

The cranial MRI includes a volumetric study that measures the size of specific brain structures — particularly the hippocampus and cortical regions — that are known to atrophy in the early stages of neurodegenerative disease. Comparing volumes against age-matched normative data can identify shrinkage patterns that precede clinical symptoms. CreuBlanca's 3 Tesla MRI equipment provides the resolution needed for accurate volumetric measurements.

The neuropsychological assessment is conducted by a psychologist using standardised cognitive testing protocols. This evaluation maps performance across memory, attention, executive function, language, and visuospatial domains, identifying subtle deficits that may not be apparent in everyday functioning. The neurological evaluation adds a clinical assessment of reflexes, coordination, and neurological signs.